Paper - WANFANG MED ONLINE

You Position: Home > Paper

Aberrant DNA Methylation in Cutaneous Squamous Cell Carcinoma

( views:0, downloads:0 )

Author:: No author available

Journal Title:: International Journal of Dermatology and Venereology

Issue:: 4

DOI:: 10.1097/JD9.0000000000000054

Key Word:: No keyword available

Abstract： IntroductionCutaneous squamous cell carcinoma (CSCC) is the secondmost common non-melanoma skin cancer after basal cell carcinoma, accounting for 20％ of all cutaneous malignancies. CSCC originates from epidermal keratinocytes or adnexal structures such as eccrine glands or pilosebaceous units.1 According to several studies focused on Caucasian populations in Europe, the USA and Australia, about 15– 35 per 100,000 individuals are diagnosed with CSCC each year, and the incidence of CSCC is expected to increase by 2％–4％ per year.2 The incidence of primary CSCC has increased by 50％–300％ globally, especially amongst Caucasian populations in New Zealand, Australia, and North America over the last 3 decades.

Reference

[1]Rachid, Zagani,Wissal, El-Assaad,Isabelle, Gamache,etc.Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells.[J].2015,6.
[2]K. Murao,Y. Kubo,N. Ohtani,etc.Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways[J].2006,155(5).
[3]Li, Liming,Jiang, Mingjun,Feng, Qinghua,etc.Aberrant Methylation Changes Detected in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals[J].2015,72(2).
[4]Irwin H, Gelman.Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.[J].2010,1.
[5]Guo, Shicheng,Diep, Dinh,Plongthongkum, Nongluk,etc.Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA[J].2017,49(4).
[6]Unamuno Bustos B.,Murria Estal R.,Pérez Simó G.,etc.Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma[J].2018,179(2).
[7]Shasha, Hou,Tian, Tian,Dianwen, Qi,etc.S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.[J].2018,9(3).
[8]Shao Y,Wu W,Yu B,etc.Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis.[J].2011,36(4).
[9]Rudland, Philip S.,Barraclough, Roger,Bennett, Daimark,etc.S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer[J].2017,77(3).
[10]Protjaroen P,Wongpiyabovorn J,Mutirangura A,etc.Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.[J].2011,42(12).
[11]Christian, Flotho,Annika, Paulun,Christiane, Batz,etc.AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.[J].2007,138(5).
[12]Cummins R,Murphy GM,O'Grady A,etc.Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients.[J].2010,163(2).
[13]Whitmarsh A,Shore P,Malhotra S,etc.Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch[J].2006,38(11).
[14]Rana, Abdel-Fattah,Adam, Glick,Ishtiaq, Rehman,etc.Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.[J].2006,118.
[15]Lin, Zhe,Deng, Lei,Ji, Jie,etc.S100A4 Hypomethylation Affects Epithelial-Mesenchymal Transition Partially Induced by LMP2A in Nasopharyngeal Carcinoma[J].2016,55(10).
[16]Katharina, Meier,Stefan K, Drexler,Franziska C, Eberle,etc.Silencing of ASC in Cutaneous Squamous Cell Carcinoma.[J].2016,(10).
[17].Distant metastases from cutaneous squamous cell carcinoma-analysis of AJCC stage IV[J].2013,35(1).
[18]Chenji,Wang,Weilin,Pu,Dunmei,Zhao,etc.Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population.[J].2018,9.
[19]Zebedee Z,Hara E.Id proteins in cell cycle control and cellular senescence.[J].2001,20(58).
[20]Dmitrovsky, Ethan,Spinella, Michael J.,Yim, Christina Y.,etc.G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancer[J].2017,16(21).
[21]Venza, Mario,Visalli, Maria,Catalano, Teresa,etc.DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients[J].2017,60.
[22]Sekula, David J.,Liu, Xi,Freemantle, Sarah J.,etc.G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program[J].2016,76(5).
[23]Tripodo B,De Grazia G,Venza M,etc.FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma.[J].2010,162(5).
[24]Fiano, Valentina,Zugna, Daniela,Grasso, Chiara,etc.LINE-1 methylation status in prostate cancer and non-neoplastic tissue adjacent to tumor in association with mortality[J].2017,12(1).
[25]Castillo-Aguilera, Omar,Depreux, Patrick,Goossens, Laurence,etc.DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.[J].2017,7(1).
[26]Vandiver, Amy R.,Irizarry, Rafael A.,Hansen, Kasper D.,etc.Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin[J].2015,16(4).
[27]Ehrlich, Melanie,Lacey, Michelle.DNA Hypomethylation and Hemimethylation in Cancer[J].2013,754.
[28]Kerachian, Mohammad Amin,Kerachian, Matin..Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer.[J].2019,488.
[29]Jian, Wu,Jin-Rong, Zhang,Jie, Qin.Clinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues.[J].2014,7(7).
[30]Kaz,A.M.,Wong,C.-J.,Dzieciatkowski,S.,etc.Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age[J].2014,9(4).
[31]Victoria L, Brown,Catherine A, Harwood,Tim, Crook,etc.p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.[J].2004,122.
[32]Yoshifumi Baba,Taisuke Yagi,Hiroshi Sawayama,etc.Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers[J].2018,97(1).
[33]Audrey, Courboulin,Roxane, Paulin,Nellie J, Giguère,etc.Role for miR-204 in human pulmonary arterial hypertension.[J].2011,208.
[34]Rotondo, John Charles,Montinari, Elena,Magri, Eros,etc.Hypermethylation-Induced Inactivation of the IRF6 Gene as a Possible Early Event in Progression of Vulvar Squamous Cell Carcinoma Associated With Lichen Sclerosus[J].2016,152(8).
[35]Junqin, Liang,Xiaojing, Kang,Yilinuer, Halifu,etc.Secreted frizzled-related protein promotors are hypermethylated in cutaneous squamous carcinoma compared with normal epidermis.[J].2015,15.
[36]van Doorn R,Tensen CP,van der Velden PA,etc.Aberrant DNA methylation in cutaneous malignancies.[J].2005,32(5).
[37].Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.[J].2018,78(2).
[38]Chaudhary, Jaideep,Morton, Derrick J.,Carey, Jason,etc.Inhibitor of differentiation 4 (ID4): From development to cancer[J].2015,1855(1).
[39]Jeffrey D,Serrill,Maike,Sander,Hung Ping,Shih.Pancreatic Exocrine Tissue Architecture and Integrity are Maintained by E-cadherin During Postnatal Development.[J].2018,8(1).
[40]Burton, Kyle A.,Ashack, Kurt A.,Khachemoune, Amor.Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease[J].2016,17(5).
[41]Dipika R,Mohan,Antonio Marcondes,Lerario,Tobias,Else,etc.Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma.[J].2019.
[42]Nicholas D L Brougham,Swee T Tan.The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.[J].2014,110(7).
[43]Nicolas F. Schlecht,Miriam Ben-Dayan,Nicole Anayannis,etc.Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma[J].2015,4(3).
[44]Kuramoto, Junko,Arai, Eri,Tian, Ying,etc.Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis[J].2017,38(3).
[45]Sun, Lidong,Kokura, Kenji,Izumi, Victoria,etc.MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition[J].2015,16(6).
[46]Kallini, Joseph R.,Hamed, Nouran,Khachemoune, Amor.Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends[J].2015,54(2).
[47]Takeuchi T,Zhou S,Liang SB,etc.Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma.[J].2002,82(8).
[48]Zhang KL,Li H,Liu ZL,etc.Methylation-associated silencing of S100A4 expression in human epidermal cancers.[J].2009,18(10).
[49]Di Piazza M,Radtke F,Dziunycz P,etc.IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes.[J].2011,30(22).
[50]Biondo, Carmelo,Catalano, Teresa,Lentini, Maria,etc.Epigenetic regulation of p14(ARF) and p16(INK4A) expression in cutaneous and uveal melanoma[J].2015,1849(3).
[51]Xu, Rui-hua,Wei, Wei,Krawczyk, Michal,etc.Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma[J].2017,16(11).
[52]Yu, Li-Jun,Li, Yan,Li, Cong,etc.Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.[J].2014,14(5).
[53]Wang, Degang,Zhang, Jianwei,Liu, Ziquan,etc.Functional expression, characterization and application of the human S100A4 protein[J].2015,11(1).
[54]Shamis Y,Sowalsky AG,Feig LA,etc.Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src.[J].2011,131(11).
[55]Nissinen, Liisa,Farshchian, Mehdi,Riihila, Pilvi,etc.New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma[J].2016,365(3).
[56]Toll, Agust��,Salgado, Roc��o,Espinet, Blanca,etc.MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.[J].2016.
[57]Svoronos, Alexander A.,Engelman, Donald M.,Slack, Frank J..OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer[J].2016,76(13).
[58]De Nicola, F.,Ganci, F.,Marinari, B.,etc.Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas[J].2011,108(33).
[59]Nobeyama, Yoshimasa,Watanabe, Yoshinori,Nakagawa, Hidemi..Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma.[J].2017,12(10).
[60]Sarkar, Debina,Baguley, Bruce C.,Askarian-Amiri, Marjan E.,etc.Epigenetic regulation in human melanoma: past and future[J].2015,10(2).
[61]Deaton AM,Bird A.CpG islands and the regulation of transcription.[J].2011,25(10).
[62]Melissa C, Chiles,Lingbao, Ai,Chunlai, Zuo,etc.E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.[J].2003,16.
[63]Hayashi,M.,Nomoto,S.,Kanda,M.,etc.Identification of the a kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma[J].2012,105(4).
[64]Wilhelm, Thomas,Lipka, Daniel B.,Witte, Tania,etc.Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia[J].2016,11(2).
[65]Kong, Yahui,Sharma, Rohit B.,Nwosu, Benjamin U.,etc.Islet biology, the CDKN2A/B locus and type 2 diabetes risk[J].2016,59(8).
[66]Masuguchi,S.,Shimozono,N.,Kobayashi,Y.,etc.Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK[J].2013,91(1).
[67]Nobeyama, Yoshimasa,Nakagawa, Hidemi..Silencing of interferon regulatory factor gene 6 in melanoma.[J].2017,12(9).
[68]Wongpiyabovorn, Jongkonnee,Ruchusatsawat, Kriangsak,Noppakun, Nopadon,etc.Patterns and functional roles of LINE-1 and Alu methylation in the keratinocyte from patients with psoriasis vulgaris[J].2015,60(7).